Startup Palleon has a sweet plan for cancer immunotherapy – FierceBiotech
FierceBiotech |
Startup Palleon has a sweet plan for cancer immunotherapy
FierceBiotech Startup Palleon has a sweet plan for cancer immunotherapy. by Phil Taylor |. Oct 4, 2017 9:25am. Glycan-sensing checkpoints enable both innate and adaptive immune responses to cancer, says Jim Broderick, M.D., Palleon's CEO and founder. |
